Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study-Reference-Cited by-同舟云学术

Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study

Published:2017-12-17 Issue:4 Volume:137 Page:392-399
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Nishida T.¹,Lee S. K.²,Inoue Y.¹,Saeki K.³,Ishikawa K.³,Kaneko S.⁴

Affiliation:

1. National Epilepsy Center; Shizuoka Institute of Epilepsy and Neurological Disorders; Shizuoka Japan

2. Department of Neurology; Seoul National University Hospital; Seoul South Korea

3. Eisai Co., Ltd.; Tokyo Japan

4. North Tohoku Epilepsy Center; Minato Hospital; Aomori Japan

Funder

Eisai

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12883/fullpdf

Reference22 articles.

1. Relief of experimental spasticity and anxiolytic/anticonvulsant actions of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline;Turski;J Pharmacol Exp Ther,1992

2. European Medicines Agency (EMA) Fycompa ® Annex I: Summary of Product Characteristics, April 2017 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002434/WC500130815.pdf

3. Food and Drug Administration (FDA) Fycompa ® Prescribing Information, July 2017 https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202834s012,208277s001lbl.pdf

4. Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304;French;Neurology,2012

5. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305;French;Epilepsia,2013

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perampanel for the treatment of Asian people with epilepsy: Real-world evidence from the PERMIT extension study;Journal of the Neurological Sciences;2024-08

2. Efficacy and safety of add‐on antiseizure medications for focal epilepsy: A network meta‐analysis;Epilepsia Open;2024-06-18

3. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis;Seizure: European Journal of Epilepsy;2024-05

4. Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy;European Journal of Paediatric Neurology;2024-05

5. Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials;eClinicalMedicine;2024-04